Camber Capital Management as of June 30, 2015
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 42 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Adr (TEVA) | 7.1 | $103M | 1.8M | 59.10 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 7.1 | $103M | 500k | 205.85 | |
| Astrazeneca Sponsored Adr (AZN) | 5.5 | $80M | 1.3M | 63.71 | |
| Select Sector Spdr Tr Sbi Healthcare Put Option (XLV) | 5.1 | $74M | 1.0M | 74.39 | |
| Masimo Corporation (MASI) | 5.0 | $74M | 1.9M | 38.74 | |
| Medicines Company | 4.9 | $72M | 2.5M | 28.61 | |
| Express Scripts Holding | 4.6 | $67M | 750k | 88.94 | |
| Cyberonics | 4.1 | $60M | 1.0M | 59.46 | |
| Genomic Health | 4.0 | $58M | 2.1M | 27.79 | |
| Select Medical Holdings Corporation (SEM) | 3.9 | $57M | 3.5M | 16.20 | |
| Universal American | 3.6 | $53M | 5.2M | 10.12 | |
| NuVasive | 3.6 | $52M | 1.1M | 47.38 | |
| Orthofix International Nv Com Stk | 3.4 | $50M | 1.5M | 33.12 | |
| Johnson & Johnson Call Option (JNJ) | 3.3 | $49M | 500k | 97.46 | |
| CIGNA Corporation | 3.3 | $49M | 300k | 162.00 | |
| Laboratory Corp Amer Hldgs Com New | 3.3 | $49M | 400k | 121.22 | |
| Ariad Pharmaceuticals | 3.3 | $48M | 5.8M | 8.27 | |
| Arena Pharmaceuticals | 2.4 | $35M | 7.5M | 4.64 | |
| Sequenom Com New | 1.9 | $27M | 9.0M | 3.04 | |
| DENTSPLY International | 1.8 | $26M | 500k | 51.55 | |
| Amarin Corp Spons Adr New (AMRN) | 1.7 | $25M | 10M | 2.46 | |
| Perrigo SHS (PRGO) | 1.6 | $23M | 123k | 184.83 | |
| Kindred Healthcare | 1.5 | $22M | 1.1M | 20.29 | |
| Cross Country Healthcare (CCRN) | 1.3 | $19M | 1.5M | 12.68 | |
| Nektar Therapeutics (NKTR) | 1.3 | $19M | 1.5M | 12.51 | |
| Quest Diagnostics Incorporated (DGX) | 1.2 | $18M | 250k | 72.52 | |
| BioScrip | 1.2 | $17M | 4.7M | 3.63 | |
| Innocoll Sponsored Adr | 1.1 | $16M | 1.1M | 14.71 | |
| Protalix BioTherapeutics | 1.0 | $14M | 7.3M | 1.95 | |
| Veracyte (VCYT) | 0.9 | $14M | 1.2M | 11.14 | |
| AngioDynamics (ANGO) | 0.8 | $12M | 735k | 16.40 | |
| DURECT Corporation | 0.8 | $12M | 5.0M | 2.39 | |
| Catabasis Pharmaceuticals | 0.8 | $11M | 928k | 12.21 | |
| Epirus Biopharmaceuticals In | 0.7 | $11M | 1.8M | 5.71 | |
| GenMark Diagnostics | 0.6 | $9.2M | 1.0M | 9.06 | |
| Invitae (NVTAQ) | 0.5 | $7.4M | 500k | 14.88 | |
| OraSure Technologies (OSUR) | 0.5 | $7.0M | 1.3M | 5.39 | |
| Protalix Biotherapeutics Note 4.500% 9/1 (Principal) | 0.5 | $7.0M | 9.0M | 0.77 | |
| Keryx Biopharmaceuticals | 0.3 | $5.0M | 500k | 9.98 | |
| Targacept | 0.3 | $4.4M | 1.6M | 2.79 | |
| Cardica | 0.3 | $4.2M | 8.4M | 0.50 | |
| Biolase Warrant Call Option | 0.0 | $319k | 7.2M | 0.04 |
